Figure 9 3.8 Proposed substrate recognition and enzyme mechanism of MSA-DH The potential substrate binding site of MSA-DH was explored by superimposing the three-dimensional structure of human succinic semialdehyde dehydrogenase in complex with its substrate (PDB ID: 2W8Q) (Kim et al., 2009) (Supplementary Figure S1)
It demonstrated to have a safety profile similar to GLP-1RA not increasing the risk of hypoglycemia ( In the SURPASS-2 study, TZP at the dose of 5, 10, and 15 mg were compared to the GLP-1RA semaglutide (1 mg once weekly) in patients not well controlled in therapy only with metformin (71)
But the average person whose CoQ10 levels are just a little lower where they should be, it really is just acting as that, kind of like you open up the biochemistry textbook, you see the place of CoQ10 in the mitochondrial energy production pathways
"It's a constant fight with food," and that invisible, daily struggle is exhausting
Many describe feeling uncomfortably full, sluggish, and unable to empty their bowels properly often for days and even weeks at a time
Consult a healthcare professional to see if GLP-1 therapy is right for you